{"transactions":[{"id":931041,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":68782,"kind":"person","name":"Robinson David Wayne","position":1,"cik":"0002107335","reported_name":"Robinson David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-27T00:15:21.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":416000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 21, 2026 and vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and the remainder vesting in equal monthly installments over the three years after such date."}],"balance_after":416000,"derivative":{"exercise_price":11.42,"expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":416000},"source":{"system":"sec-edgar","filing":"0001104659-26-006711","document":"tm263977-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926006711/tm263977-2_4seq1.xml","form_type":"4"}},{"id":931040,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":68782,"kind":"person","name":"Robinson David Wayne","position":1,"cik":"0002107335","reported_name":"Robinson David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global CCO"}}],"security":"Common Stock","published_at":"2026-01-27T00:15:21.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 21, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":136000,"source":{"system":"sec-edgar","filing":"0001104659-26-006711","document":"tm263977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926006711/tm263977-2_4seq1.xml","form_type":"4"}}]}